We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

123 hedge funds and large institutions have $545M invested in Sarepta Therapeutics in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $102M | Put options by funds: $37M

5% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 39

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 128 → 123 (-5)

17% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 24

31% less capital invested

Capital invested by funds: $794M → $545M (-$249M)

Holders
123
Holders Change
-5
Holders Change %
-3.91%
% of All Funds
3.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
41
Reduced
39
Closed
24
Calls
$102M
Puts
$37M
Net Calls
+$65.4M
Net Calls Change
+$79.9M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$23.1M
2
CWAM
Columbia Wanger Asset Management
Illinois
+$13.6M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.28M
4
TCM
Tekla Capital Management
Massachusetts
+$7.8M
5
CA
Commerzbank Aktiengesellschaft
Germany
+$5.74M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$53.7M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$12.6M
3
SFM
Soros Fund Management
New York
-$8.01M
4
JG
Jefferies Group
New York
-$3.92M
5
Millennium Management
Millennium Management
New York
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
EMFAT
26
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.59M -$130K -5,740 -3%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$4.55M -$41.8K -1,853 -0.9%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.54M +$317K +14,064 +7%
JG
29
Jefferies Group
New York
$3.88M -$3.92M -173,604 -49%
GC
30
Guggenheim Capital
Illinois
$2.66M +$687K +30,429 +32%
BIM
31
BlackRock Investment Management
Delaware
$2.36M +$9.34K +414 +0.4%
Charles Schwab
32
Charles Schwab
California
$2.31M +$51.1K +2,263 +2%
CS
33
Credit Suisse
Switzerland
$2.3M +$691K +30,602 +39%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$2.25M – – –
TA
35
Teachers Advisors
New York
$2.22M +$233K +10,341 +11%
Morgan Stanley
36
Morgan Stanley
New York
$2.14M -$191K -8,447 -8%
PCM
37
Palisade Capital Management
New Jersey
$1.99M +$2.13M +94,503 New
Millennium Management
38
Millennium Management
New York
$1.85M -$2.92M -129,413 -60%
Deutsche Bank
39
Deutsche Bank
Germany
$1.72M +$27.3K +1,211 +2%
Group One Trading
40
Group One Trading
Illinois
$1.71M +$737K +32,642 +68%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$1.58M +$18.6K +826 +1%
U
42
UBS
Switzerland
$1.57M -$23.7K -1,049 -1%
AllianceBernstein
43
AllianceBernstein
Tennessee
$1.42M – – –
ST
44
Spot Trading
Illinois
$1.4M +$624K +27,645 +71%
PCM
45
Proxima Capital Management
New York
$1.18M +$135K +6,000 +12%
BCA
46
Benchmark Capital Advisors
New York
$1.15M +$437K +19,350 +55%
GACM
47
Green Arrow Capital Management
New York
$1.05M +$1.13M +50,000 New
USAA
48
United Services Automobile Association
Texas
$908K – – –
Macquarie Group
49
Macquarie Group
Australia
$907K +$158K +7,000 +19%
Swiss National Bank
50
Swiss National Bank
Switzerland
$863K – – –
1
2
3 4 5

SRPT Hedge Fund Activity: Q3 2014 in Review

123 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q3 2014, worth a combined $545M — down 31% from $794M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of SRPT and 20 opened new positions — a net loss of 4 holders — while 39 trimmed existing stakes and 41 added.

The largest buyer was Jennison Associates, opening a new position worth an estimated $23.1M. The largest seller was Lord, Abbett & Co, cutting an estimated $53.7M.

  • 123 institutional investors held Sarepta Therapeutics (SRPT) as of Q3 2014, down from 128 in Q2 2014.
  • Funds reported $545M of Sarepta Therapeutics stock for Q3 2014, down 31% quarter-over-quarter.
  • 20 funds opened new Sarepta Therapeutics positions in Q3 2014 and 24 closed out, a net change of -4 holders.
  • The largest Sarepta Therapeutics buyer in Q3 2014 was Jennison Associates, an estimated $23.1M added.
  • The largest Sarepta Therapeutics seller in Q3 2014 was Lord, Abbett & Co, an estimated $53.7M sold.

Based on aggregated 13F filings for Q3 2014.